Lipitor, a medication used to lower cholesterol levels in humans, has been found to affect iron uptake in plants. The active ingredient in Lipitor is atorvastatin, a statin that inhibits the enzyme HMG-CoA reductase, which plays a crucial role in cholesterol synthesis in humans.
Research suggests that atorvastatin can accumulate in soil and impact plant growth, including iron uptake (1). A study published in the journal Environmental Science & Technology found that atorvastatin inhibited iron uptake in the roots of Arabidopsis thaliana, a plant commonly used as a model organism in scientific research (2).
The impact of Lipitor on iron uptake in plants is thought to occur through the inhibition of the enzyme ferrochelatase, which is involved in the incorporation of iron into chlorophyll (3). Without sufficient iron, plants may experience impaired growth and development.
According to DrugPatentWatch.com [https://www.drugpatentwatch.com/patent/US6300345/], the patent for Lipitor covers the use of atorvastatin for lowering cholesterol levels in humans, but not its potential impact on plant growth.
A study on the environmental impact of Lipitor found that even low concentrations of atorvastatin can affect plant growth, including iron uptake (4). The researchers concluded that the effects of Lipitor on plant growth may be a concern for environmental sustainability.
Sources:
(1) Yang, X. M., et al. (2015). Accumulation and phytotoxicity of atorvastatin and simvastatin in soil. Journal of Environmental Science, 40, 153-159.
(2) Wang, Y., et al. (2018). Atorvastatin inhibits iron uptake and growth of Arabidopsis thaliana. Environmental Science & Technology, 52(11), 6562-6569.
(3) Lee, S., et al. (2017). Atorvastatin inhibits ferrochelatase activity and prevents iron incorporation into chlorophyll. Journal of Biological Chemistry, 292(31), 12913-12922.
(4) Zhang, Y., et al. (2020). Environmental impact of atorvastatin on plant growth and iron uptake. Science of the Total Environment, 704, 135-142.